Takeda Pharmaceutical Co Stock Price History
| TAK Stock | USD 14.30 0.01 0.07% |
Below is the normalized historical share price chart for Takeda Pharmaceutical Co extending back to March 06, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Takeda Pharmaceutical stands at 14.30, as last reported on the 12th of October 2024, with the highest price reaching 14.31 and the lowest price hitting 14.11 during the day.
If you're considering investing in Takeda Stock, it is important to understand the factors that can impact its price. As of now, Takeda Stock is very steady. Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0943, which indicates the firm had a 0.0943% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Takeda Pharmaceutical Co, which you can use to evaluate the volatility of the company. Please validate Takeda Pharmaceutical's Coefficient Of Variation of 934.53, risk adjusted performance of 0.0908, and Semi Deviation of 0.9855 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Takeda Pharmaceutical's Capital Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 74.4 B this year, although the value of Sale Purchase Of Stock will most likely fall to (2.4 B). . Price Earnings Ratio is expected to rise to 24.82 this year, although the value of Price To Sales Ratio will most likely fall to 0.72. Takeda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of October 2008 | 200 Day MA 14.0002 | 50 Day MA 14.5368 | Beta 0.498 |
Takeda |
Sharpe Ratio = 0.0943
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | TAK | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.16 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Takeda Pharmaceutical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Takeda Pharmaceutical by adding it to a well-diversified portfolio.
Price Book 0.8618 | Enterprise Value Ebitda 12.35 | Price Sales 0.0103 | Shares Float 1.6 B | Dividend Share 188 |
Takeda Pharmaceutical Stock Price History Chart
There are several ways to analyze Takeda Stock price data. The simplest method is using a basic Takeda candlestick price chart, which shows Takeda Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | August 23, 2024 | 15.08 |
| Lowest Price | August 6, 2024 | 13.31 |
Takeda Pharmaceutical October 12, 2024 Stock Price Synopsis
Various analyses of Takeda Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Takeda Stock. It can be used to describe the percentage change in the price of Takeda Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Takeda Stock.| Takeda Pharmaceutical Accumulation Distribution | 44,110 | |
| Takeda Pharmaceutical Price Action Indicator | 0.09 | |
| Takeda Pharmaceutical Price Daily Balance Of Power | (0.05) | |
| Takeda Pharmaceutical Price Rate Of Daily Change | 1.00 |
Takeda Pharmaceutical October 12, 2024 Stock Price Analysis
Takeda Stock Price History Data
The price series of Takeda Pharmaceutical for the period between Sun, Jul 14, 2024 and Sat, Oct 12, 2024 has a statistical range of 1.83 with a coefficient of variation of 3.96. The price distribution for the period has arithmetic mean of 14.3. The median price for the last 90 days is 14.33. The company had dividends distributed to its stock-holders on 2024-03-27.| Open | High | Low | Close | Volume | ||
| 10/11/2024 | 14.12 | 14.31 | 14.11 | 14.30 | 3,156,092 | |
| 10/10/2024 | 14.29 | 14.32 | 14.23 | 14.31 | 909,292 | |
| 10/09/2024 | 14.25 | 14.30 | 14.21 | 14.28 | 1,936,584 | |
| 10/08/2024 | 14.30 | 14.34 | 14.25 | 14.30 | 2,092,685 | |
| 10/07/2024 | 14.31 | 14.43 | 14.29 | 14.33 | 2,078,612 | |
| 10/04/2024 | 14.29 | 14.49 | 14.29 | 14.43 | 1,791,777 | |
| 10/03/2024 | 14.25 | 14.29 | 14.19 | 14.24 | 1,407,728 | |
| 10/02/2024 | 14.24 | 14.33 | 14.19 | 14.32 | 1,530,078 | |
| 10/01/2024 | 14.35 | 14.36 | 14.21 | 14.28 | 1,369,646 | |
| 09/30/2024 | 14.44 | 14.44 | 14.18 | 14.22 | 2,770,759 | |
| 09/27/2024 | 14.62 | 14.67 | 14.54 | 14.54 | 1,628,905 | |
| 09/26/2024 | 14.63 | 14.67 | 14.57 | 14.65 | 842,921 | |
| 09/25/2024 | 14.72 | 14.73 | 14.55 | 14.58 | 5,769,956 | |
| 09/24/2024 | 14.79 | 14.85 | 14.73 | 14.80 | 2,326,713 | |
| 09/23/2024 | 14.77 | 14.92 | 14.76 | 14.89 | 1,905,031 | |
| 09/20/2024 | 14.85 | 14.87 | 14.76 | 14.80 | 1,241,150 | |
| 09/19/2024 | 14.82 | 14.94 | 14.82 | 14.93 | 1,119,004 | |
| 09/18/2024 | 14.87 | 14.94 | 14.78 | 14.82 | 1,569,729 | |
| 09/17/2024 | 14.87 | 14.95 | 14.83 | 14.85 | 1,922,060 | |
| 09/16/2024 | 14.72 | 14.81 | 14.69 | 14.80 | 1,930,108 | |
| 09/13/2024 | 14.69 | 14.85 | 14.66 | 14.70 | 2,608,681 | |
| 09/12/2024 | 14.79 | 14.83 | 14.71 | 14.82 | 779,543 | |
| 09/11/2024 | 14.74 | 14.83 | 14.69 | 14.82 | 1,012,119 | |
| 09/10/2024 | 14.85 | 14.89 | 14.81 | 14.89 | 1,027,867 | |
| 09/09/2024 | 14.83 | 14.94 | 14.83 | 14.88 | 1,103,402 | |
| 09/06/2024 | 14.89 | 14.92 | 14.79 | 14.81 | 1,480,340 | |
| 09/05/2024 | 14.98 | 14.99 | 14.86 | 14.92 | 1,577,153 | |
| 09/04/2024 | 14.84 | 15.00 | 14.84 | 14.98 | 972,526 | |
| 09/03/2024 | 14.84 | 15.00 | 14.84 | 14.92 | 2,147,945 | |
| 08/30/2024 | 14.83 | 14.93 | 14.80 | 14.89 | 1,859,541 | |
| 08/29/2024 | 14.97 | 15.00 | 14.92 | 14.95 | 1,024,919 | |
| 08/28/2024 | 14.87 | 15.06 | 14.87 | 14.97 | 2,105,586 | |
| 08/27/2024 | 14.92 | 15.04 | 14.92 | 14.96 | 1,371,923 | |
| 08/26/2024 | 14.89 | 14.94 | 14.79 | 14.82 | 1,490,315 | |
| 08/23/2024 | 14.93 | 15.08 | 14.92 | 15.08 | 2,564,957 | |
| 08/22/2024 | 14.99 | 15.00 | 14.84 | 14.88 | 2,329,312 | |
| 08/21/2024 | 14.90 | 14.96 | 14.85 | 14.94 | 2,231,270 | |
| 08/20/2024 | 14.74 | 14.81 | 14.73 | 14.76 | 2,096,542 | |
| 08/19/2024 | 14.54 | 14.72 | 14.51 | 14.72 | 2,088,387 | |
| 08/16/2024 | 14.45 | 14.50 | 14.41 | 14.50 | 1,374,816 | |
| 08/15/2024 | 14.43 | 14.47 | 14.40 | 14.44 | 1,271,101 | |
| 08/14/2024 | 14.19 | 14.33 | 14.17 | 14.30 | 1,838,135 | |
| 08/13/2024 | 13.90 | 14.06 | 13.90 | 14.06 | 1,367,419 | |
| 08/12/2024 | 13.80 | 13.89 | 13.77 | 13.85 | 1,379,136 | |
| 08/09/2024 | 13.77 | 13.91 | 13.76 | 13.87 | 1,519,706 | |
| 08/08/2024 | 13.79 | 13.91 | 13.75 | 13.87 | 1,912,769 | |
| 08/07/2024 | 13.81 | 13.98 | 13.76 | 13.81 | 3,184,722 | |
| 08/06/2024 | 13.38 | 13.49 | 13.29 | 13.31 | 4,109,946 | |
| 08/05/2024 | 13.43 | 13.87 | 13.41 | 13.82 | 5,744,891 | |
| 08/02/2024 | 13.71 | 14.13 | 13.71 | 14.08 | 3,899,920 | |
| 08/01/2024 | 13.60 | 13.85 | 13.52 | 13.85 | 4,409,218 | |
| 07/31/2024 | 13.57 | 13.93 | 13.35 | 13.88 | 4,490,749 | |
| 07/30/2024 | 13.67 | 13.70 | 13.54 | 13.65 | 3,617,048 | |
| 07/29/2024 | 13.86 | 13.88 | 13.62 | 13.70 | 6,187,734 | |
| 07/26/2024 | 13.69 | 13.79 | 13.69 | 13.77 | 2,454,805 | |
| 07/25/2024 | 13.70 | 13.83 | 13.65 | 13.67 | 3,278,675 | |
| 07/24/2024 | 13.66 | 13.72 | 13.54 | 13.58 | 2,276,117 | |
| 07/23/2024 | 13.63 | 13.67 | 13.52 | 13.66 | 2,368,719 | |
| 07/22/2024 | 13.40 | 13.57 | 13.40 | 13.51 | 2,261,460 | |
| 07/19/2024 | 13.40 | 13.42 | 13.24 | 13.36 | 4,167,467 | |
| 07/18/2024 | 13.60 | 13.66 | 13.43 | 13.49 | 2,274,718 |
About Takeda Pharmaceutical Stock history
Takeda Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Takeda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Takeda Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Takeda Pharmaceutical stock prices may prove useful in developing a viable investing in Takeda Pharmaceutical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.6 B | 1.3 B | |
| Net Income Applicable To Common Shares | 364.6 B | 382.8 B |
Takeda Pharmaceutical Stock Technical Analysis
Takeda Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Takeda Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Takeda Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Takeda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Takeda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0908 | |||
| Jensen Alpha | 0.083 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0167 | |||
| Treynor Ratio | 0.3533 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 188 | Earnings Share 0.32 | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.141 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.